Reaction
Infective Aneurysm reporting signals
As of the last recalculation, Infective Aneurysm appears in 482 FAERS reports alongside 32 co-occurring drug terms. The strongest observed disproportionality signal is BASILIXIMAB (PRR 113.2).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Basiliximab | 29 | 113.2 | 113.5 |
| Valganciclovir Hydrochloride Powder, | 20 | 73.8 | 74.0 |
| Isoniazid | 22 | 61.4 | 61.5 |
| Voriconazole Injection | 28 | 59.1 | 59.1 |
| Micafungin Sodium | 11 | 57.3 | 57.4 |
| Heparin Sodium | 17 | 55.3 | 55.4 |
| Valganciclovir | 22 | 52.8 | 52.8 |
| Valganciclovir Hydrochloride | 22 | 52.8 | 52.8 |
| Anti-Thymocyte Globulin (Rabbit) | 9 | 49.1 | 49.1 |
| Nevirapine | 10 | 48.9 | 48.9 |
| Tacrolimus Ointment 0.1% | 106 | 46.8 | 46.9 |
| Tacrolimus Extended-Release Capsules | 106 | 46.7 | 46.8 |
| Abacavir Sulfate | 10 | 45.2 | 45.3 |
| Meropenem | 31 | 44.5 | 44.6 |
| Rifampin | 14 | 42.6 | 42.7 |
| Voriconazole | 28 | 42.2 | 42.2 |
| Tenofovir Disoproxil Fumarate Tablets | 8 | 40.7 | 40.7 |
| Rifampicin | 9 | 39.1 | 39.2 |
| Tacrolimus | 109 | 38.5 | 38.6 |
| Gentamicin | 11 | 37.1 | 37.2 |
| Posaconazole Delayed-Release | 9 | 36.0 | 36.1 |
| Drs. Clotrimazole | 9 | 34.2 | 34.3 |
| Family Wellness Clotrimazole | 9 | 34.2 | 34.3 |
| Clotrimazole Topical | 9 | 34.2 | 34.3 |
| Gentamicin Sulfate | 12 | 33.6 | 33.6 |
| Zidovudine | 10 | 33.0 | 33.0 |
| Ceftriaxone | 23 | 31.7 | 31.8 |
| Ceftriaxone Sodium | 25 | 29.6 | 29.7 |
| Amphotericin B | 8 | 28.0 | 28.0 |
| Posaconazole | 9 | 24.4 | 24.4 |
| Azacitidine For | 9 | 21.8 | 21.8 |
| Deferasirox | 12 | 20.0 | 20.0 |